ExLibris header image
SFX Logo
Title: The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers
Source:

European Journal of Clinical Pharmacology [0031-6970] Munafo, A yr:1992


Collapse list of basic services Basic
Full text
Full text available via SpringerLINK Contemporary 1997-Present
GO
Full text available via SpringerLink Historical Archives Biomedical and Life Sciences
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Lewis, G P. "Interaction of flecainide with digoxin and propranolol." The American journal of cardiology 53.5 (1984): 52-57. Link to Full Text for this item Link to SFX for this item
2. Coumel, P. "Flecainide acetate dose-concentration relationship in cardiac arrhythmias: influence of heart failure and amiodarone." Cardiovascular drugs and therapy (1990): 1161-5. Link to Full Text for this item Link to SFX for this item
3. Jaillon, M. "Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone." Clinical pharmacology and therapeutics 55.3 (1994): 256-69. Link to SFX for this item
4. Holtzman, Jordan L. "The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearance." Clinical pharmacology & therapeutics 46.1 (1989): 26-32. Link to SFX for this item
5. MIKUS, G. "THE INFLUENCE OF THE SPARTEINE DEBRISOQUIN PHENOTYPE ON THE DISPOSITION OF FLECAINIDE." Clinical pharmacology and therapeutics 45.5 (1989): 562-567. Link to SFX for this item
6. Walls, J. "Pharmacokinetics of flecainide acetate in patients with severe renal impairment." Clinical pharmacology and therapeutics 43.4 (1988): 449-55. Link to SFX for this item
7. Conard, G J. "The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance." European journal of clinical pharmacology 33.1 (1987): 97-99. Link to Full Text for this item Link to SFX for this item
8. Kroemer, Heyo K. "Flecainide enantiomers: Disposition in human subjects and electrophysiologic actions in vitro." Clinical pharmacology & therapeutics 46.5 (1989): 584-590. Link to SFX for this item
9. Holtzman, J L. "Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate." Clinical pharmacology & therapeutics (1989): 1-8. Link to SFX for this item
10. Sanjurjo, P. "[Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation]." Revista española de cardiología 58.6 (2005): 745-8. Link to SFX for this item
11. Young, K.V. Y. "Recent advances in understanding hormonal therapy resistant prostate cancer." Current cancer drug targets 10.4 (2010): 402-410. Link to SFX for this item
12. LAL, R. "FLECAINIDE AND AMIODARONE INTERACTION." Journal of the American College of Cardiology 7.5 (1986): 1127-1130. Link to SFX for this item
13. Funck-Bretano, C. "Influence of amiodarone on genetically determined drug metabolism in humans." Clinical pharmacology and therapeutics 50.3 (1991): 259-266. Link to SFX for this item
14. Luan, F. "Prediction of pKa for neutral and basic drugs based on radial basis function neural networks and the heuristic method." Pharmaceutical Research 22.9 (2005): 1454-1460. Link to Full Text for this item Link to SFX for this item
15. Tenneze, L. "Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: Comparison with the standard form and influence of the CYP2D6 polymorphism." Clinical pharmacology and therapeutics 72.2 (2002): 112-122. Link to SFX for this item
16. 新, 博次. "Flecainide (E-0735)臨床第1相試験." 臨床薬理 19.3 (1988): 563-572. Link to SFX for this item
17. Doki, K. "CYP2D6 genotype affects age-related decline in flecainide clearance." Pharmacogenetics and genomics 22.11 (2012): 777-783. Link to SFX for this item
18. Mitchell, L B. "Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects." Circulation 80.1 (1989): 34-42. Link to SFX for this item
19. Nahata, J U C. "Pharmacokinetics of fluconazole after oral administration in children with human immunodeficiency virus infection." European journal of clinical pharmacology 48.3-4 (1995): 291-293. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.